Cartesian Bio Competitors and Similar CompaniesClear all
Cartesian Bio's competitors and similar companies include VITRUVIAN BioMedical, Bio Farma, Shandong Saito Biotechnology and Walvax Biotechnology.
 Cartesian Bio Cartesian Bio (formerly known as Cartesian Therapeutics) is a biopharmaceutical company developing cell and gene immunotherapies to treat cancer and autoimmune diseases. |  VITRUVIAN BioMedical VITRUVIAN BioMedical is a biotechnology company engaged in the development and commercialization of diagnostics and therapeutics with an initial focus on Alzheimer's Disease. |  Shandong Saito Biotechnology Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. |  Walvax Biotechnology Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs. | ||
Founding Date | Founding Date 2016 | Founding Date 2010 | Founding Date 1890 | Founding Date 2010 | Founding Date 2001 |
Type | Type Subsidiary | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Gaithersburg, US HQ | Locations Addison, US HQ | Locations ID HQ | Locations Heze, CN HQ | Locations Kunming, CN HQ |
Employees | Employees 845% increase | Employees 6 | Employees 1,233 | Employees 95920% decrease | Employees 2,388 |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 708.6 m | Valuation ($) 3.3 b |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) ¥961.3m (FY, 2025) | Revenue (est.) ¥2.4b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods ¥864.3m (FY, 2025) | Cost of goods ¥615.2m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit ¥140.3m (FY, 2025) | Gross profit ¥1.8b (FY, 2025) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income (¥84.7m) (FY, 2025) | Net income ¥125.2m (FY, 2025) |
For sources of this data, please see the company profile
View Company Profiles
VITRUVIAN BioMedical
HQ
Addison, US
Employees
6
VITRUVIAN BioMedical is a biotechnology company engaged in the development and commercialization of diagnostics and therapeutics with an initial focus on Alzheimer's Disease.
View companyShandong Saito Biotechnology
HQ
Heze, CN
Employees
959↓ 20% decrease
Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates.
View companyWalvax Biotechnology
HQ
Kunming, CN
Employees
2,388
Walvax Biotechnology (also known as Yunnan Watson Biotechnology, 云南沃森生物技术股份有限公司) is a company that is engaged in the research and development, production, and sales of human vaccines and biotechnology drugs.
View company